No Data
Jin Huo 30th Anniversary Series Event | Longde Health Industry Park Grand Opening, Jin Huo Writes a New Chapter in the Health Industry.
On November 26, 2024, the grand opening ceremony of the Kingworld-Longde Health Industry Park was held in Shenzhen, marking the beginning of the 30th anniversary celebration of Kingworld Group. On the same day, the new product 'Foci-Kingworld Angong Niuhuang Pills' jointly launched by Foci and Kingworld was also listed and debuted, a series of milestone celebration activities indicating Kingworld Pharmaceuticals' confidence and determination to continue to write a new chapter in the medical and health industry. After four years of hard work, the Longde Park creates a new business card for Longgang Health. The Longde Health Industry Park is developed by Kingworld Pharmaceuticals (01110.HK) in accordance with the national health industry development strategy combined with the industrial development plans of Shenzhen and Longgang District.
Kingworld Medicines Launches Longde Health Industrial Park
Kingworld (01110.HK): The Longde Health Industry Park has officially been put into operation.
Grunt 26 November, kingworld (01110.HK) announced that the board of directors is pleased to announce that the Longde Health Industry Park has officially started operating since 26 November 2024. Longde Health Industry Park is located in Baolong Technology City, Longgang District, Shenzhen, China, at the heart of the East Core of Longgang District composed of the high-speed rail new town and international low-carbon city in the east of Shenzhen. Longde Health Industry Park is listed as a major project in Longgang District. The group plans to leverage the geographical advantages and policy support of the Greater Bay Area, integrate resources in the pharmaceutical industry supply chain, and further develop the Longde Health Industry Park. The board of directors believes that Longde Health Industry Park
Kingworld (01110.HK) announced that director and chairman Zhao Lisheng increased his shareholding by 1 million shares.
According to the latest equity disclosure information from the Stock Exchange on November 25, Gelonghui reported that on November 20, 2024, kingworld (01110.HK) saw its executive director and chairman Zhao Lisheng increase his shareholding by purchasing 1 million shares at an average price of HKD 0.4635 per share, involving approximately HKD 0.4635 million. After the increase, Zhao Lisheng's latest shareholding is 412,980,250 shares, with his ownership percentage rising from 66.18% to 66.34%.
Li Sheng Zhao Spends CN¥436k On Kingworld Medicines Group Stock
Ex-Kingworld Medicines Employees Face Fraud Charges
No Data
No Data